UB Paderborn / Katalog / Suche / in CDI

Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy

Cancer, 2019-12, Vol.125 (S24), p.4582-4586

2019

Link zum Volltext

Verfügbarkeit prüfen

Leptomeningeal metastases arising from gynecological cancers

International journal of clinical oncology, 2020-02, Vol.25 (2), p.391-395

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer

International journal of clinical oncology, 2021-01, Vol.26 (1), p.207-215

2021

Link zum Volltext

Verfügbarkeit prüfen

Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group

International journal of gynecological cancer, 2018-01, Vol.28 (1), p.99-106

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021)

International journal of clinical oncology, 2022-01, Vol.27 (1), p.1-6

2022

Link zum Volltext

Verfügbarkeit prüfen

Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy

International journal of clinical oncology, 2020-09, Vol.25 (9), p.1718-1725

2020

Link zum Volltext

Verfügbarkeit prüfen

Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study

International journal of clinical oncology, 2020-03, Vol.25 (3), p.502-507

2020

Link zum Volltext

Verfügbarkeit prüfen

Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary

International journal of clinical oncology, 2021-07, Vol.26 (7), p.1336-1344

2021

Link zum Volltext

Verfügbarkeit prüfen

Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors

Gynecologic oncology, 2017-12, Vol.147 (3), p.585-588

2017

Link zum Volltext

Verfügbarkeit prüfen

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

Gynecologic oncology, 2013-12, Vol.131 (3), p.567-573

2013

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study

International journal of clinical oncology, 2021-07, Vol.26 (7), p.1314-1321

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumor size before image-guided brachytherapy is an important factor of local control after radiotherapy for cervical squamous cell carcinoma: analysis in cases using central shielding

Journal of radiation research, 2022-07, Vol.63 (5), p.772-779

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of prior olaparib maintenance therapy for platinum sensitive recurrent ovarian cancer on response to subsequent platinum‐based chemotherapy

The journal of obstetrics and gynaecology research, 2022-05, Vol.48 (5), p.1248-1254

2022

Link zum Volltext

Verfügbarkeit prüfen

Association between financial toxicity and health-related quality of life of patients with gynecologic cancer

International journal of clinical oncology, 2023-03, Vol.28 (3), p.454-467

2023

Link zum Volltext

Verfügbarkeit prüfen

Quality of life assessment of cell‐free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study

The journal of obstetrics and gynaecology research, 2021-04, Vol.47 (4), p.1536-1543

2021

Link zum Volltext

Verfügbarkeit prüfen

Revival of Intraperitoneal Chemotherapy for Advanced Epithelial Ovarian Cancer

Gan to kagaku ryoho, 2023-02, Vol.50 (2), p.171

Nagao, Shoji

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategy for locally advanced squamous cell cervical cancer with clinically positive pelvic lymph nodes metastasis

The journal of obstetrics and gynaecology research, 2021-07, Vol.47 (7), p.2442-2448

2021

Link zum Volltext

Verfügbarkeit prüfen

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

International journal of clinical oncology, 2023-01, Vol.28 (1), p.163-174

2023

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix

International journal of clinical oncology, 2016-12, Vol.21 (6), p.1128-1135

2016

Link zum Volltext

Verfügbarkeit prüfen

Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy

BMC cancer, 2020-11, Vol.20 (1), p.1169-13, Article 1169

2020

Link zum Volltext

Verfügbarkeit prüfen

Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma

International journal of clinical oncology, 2021-07, Vol.26 (7), p.1322-1329

2021

Link zum Volltext

Verfügbarkeit prüfen

A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer

Japanese journal of clinical oncology, 2016-06, Vol.46 (6), p.517-521

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)

International journal of clinical oncology, 2019-10, Vol.24 (10), p.1284-1291

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

Journal of ovarian research, 2020-02, Vol.13 (1), p.14-14, Article 14

2020

Link zum Volltext

Verfügbarkeit prüfen

Successful endoscopic treatment for high-grade cervical intraepithelial neoplasia with gross lesions of the vagina

Gynecology and minimally invasive therapy, 2021-04, Vol.10 (2), p.124-126

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy

Leptomeningeal metastases arising from gynecological cancers

Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer

Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group

Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021)

Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy

Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study

Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary

Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study

Tumor size before image-guided brachytherapy is an important factor of local control after radiotherapy for cervical squamous cell carcinoma: analysis in cases using central shielding

Effect of prior olaparib maintenance therapy for platinum sensitive recurrent ovarian cancer on response to subsequent platinum‐based chemotherapy

Association between financial toxicity and health-related quality of life of patients with gynecologic cancer

Quality of life assessment of cell‐free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study

Revival of Intraperitoneal Chemotherapy for Advanced Epithelial Ovarian Cancer

Treatment strategy for locally advanced squamous cell cervical cancer with clinically positive pelvic lymph nodes metastasis

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix

Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy

Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma

A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer

A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)

A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

Successful endoscopic treatment for high-grade cervical intraepithelial neoplasia with gross lesions of the vagina

Suchergebnisse filtern